Pancreatic alpha-cell glucagon secretion machinery

The pancreatic alpha-cell glucagon secretion machinery is a complex integrated system responsible for the synthesis, storage, and regulated release of glucagon, the primary counter-regulatory hormone to insulin. This machinery involves a variety of molecular components, including ATP-sensitive potassium (K_ATP) channels, voltage-gated calcium and sodium channels, and various G protein-coupled receptors (GPCRs) such as the somatostatin receptor 2 (SSTR2) and the glucagon-like peptide-1 receptor (GLP1R) (Gylfe & Gilon, 2014; Quesada et al., 2008). Under low glucose conditions, the machinery triggers action potentials and calcium influx, leading to the exocytosis of glucagon granules to elevate blood glucose levels via hepatic glycogenolysis and gluconeogenesis (Gromada et al., 2007). In diabetes, this machinery often becomes dysfunctional, leading to inappropriate hyperglucagonemia which exacerbates hyperglycemia (Zhang et al., 2013). Therapeutic strategies targeting this system include GLP-1 receptor agonists and somatostatin analogs, which inhibit glucagon release, as well as emerging research into direct alpha-cell modulators to restore glucose counter-regulation.

Other names

Alpha-cell secretory apparatusGlucagon release pathwayIslet alpha-cell stimulus-secretion couplingGlucagon exocytotic machinery

Inhibition of glucagon release via GPCR activation (GLP1R, SSTR2), modulation of ion channel conductance (K_ATP, VGCC), and enhancement of paracrine inhibitory signals from neighboring beta and delta cells.